Combined Effect of Homocysteine and Uric Acid to Identify Patients With High Risk for Subclinical Atrial Fibrillation

Combined Effect of Homocysteine and Uric Acid to Identify Patients With High Risk for Subclinical Atrial Fibrillation

Background Subclinical atrial fibrillation (SCAF) is often asymptomatic nonetheless harmful. In patients with cardiac implantable electronic devices, we evaluated the combined performance of homocysteine and uric acid (UA) biomarkers to discriminate high‐risk patients for SCAF. Methods and Results W...

Full description

Bibliographic Details
Main Authors: Shihao Wang, Yushan Wei, Tesfaldet Habtemariam Hidru, Daobo Li, Nan Wang, Yiheng Yang, Yunsong Wang, Xiaolei Yang, Yunlong Xia
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
continuous monitoring
homocysteine
pacemaker
subclinical atrial fibrillation
uric acid
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.121.021997

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.121.021997

Similar Items